Efficacy of phenazone in the treatment of acute migraine attacks: a double-blind, placebo-controlled, randomized study

Cephalalgia : an International Journal of Headache
H GöbelV Zumbroich

Abstract

In this study we compared the efficacy of 1000 mg phenazone with that of placebo in the treatment of acute migraine attacks in a randomized double-blind, placebo-controlled study of 208 patients. The main target criterion was the number of patients with a pain reduction from severe or moderate to slight or no pain 2 h after taking the pain medication. The percentage of patients satisfying the main target criterion was 48.6% for phenazone and 27.2% (P < 0.05) for placebo. Freedom from pain after 2 h was reported by 27.6% with phenazone treatment and 13.6% (P < 0.05) with placebo. Compared with placebo, the phenazone treatment also resulted in a significant improvement in the associated migraine symptoms of nausea, phonophobia and photophobia. Of patients treated with phenazone 11.4%, and 5.8% of those treated with placebo reported adverse events. There was no significant difference between the groups with regard to numbers of patients with adverse events. No serious adverse events occurred. The results show that phenazone at a dosage of 1000 mg is effective and well tolerated in the treatment of acute migraine attacks.

References

Jan 1, 1996·European Journal of Clinical Pharmacology·H G KraetschG Kobal
Jan 25, 2002·The New England Journal of Medicine·Peter J GoadsbyMichel D Ferrari
Apr 10, 2002·American Journal of Therapeutics·Kay Brune
Apr 12, 2002·Lancet·Peer Tfelt-Hansen
Apr 23, 2002·Headache·Richard B LiptonJeffrey M Dayno

❮ Previous
Next ❯

Citations

Jul 5, 2005·Der Internist·H-C Diener, V Limmroth
Jun 27, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies· P S Sándor
Aug 28, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S EversUNKNOWN European Federation of Neurological Societies
Jul 1, 2012·Pain Management·Mari Bozoghlanian, Sridhar V Vasudevan
Feb 4, 2016·Pain Research and Treatment·Rubesh GooriahFayyaz Ahmed
Oct 12, 2010·The Journal of Headache and Pain·Anders Hougaard, Peer Tfelt-Hansen
Jun 23, 2016·SpringerPlus·Fabio AntonaciAlfredo Costa
Jan 28, 2012·Stroke; a Journal of Cerebral Circulation·Wolf-Dieter HeissUNKNOWN Cerebrolysin Acute Stroke Treatment in Asia (CASTA) Investigators
Feb 27, 2013·The Cochrane Database of Systematic Reviews·Virginia WongVanessa Chu

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy test

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.